About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2006 (2006), Article ID 12129, 3 pages
http://dx.doi.org/10.1155/JBB/2006/12129
Review Article

Interplay Between Oxidative Damage, Protein Synthesis, and Protein Degradation in Alzheimer's Disease

Anatomy and Neurobiology, Sanders Brown Center on Aging, University of Kentucky, Lexington 40536, KY, USA

Received 4 November 2005; Revised 31 January 2006; Accepted 1 February 2006

Copyright © 2006 Jeffrey N. Keller. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W R Markesbery, “Neuropathological criteria for the diagnosis of Alzheimer's disease,” Neurobiology of Aging, vol. 18, no. 4 suppl, pp. S13–S19, 1997. View at Publisher · View at Google Scholar
  2. H M Wisniewski and W Silverman, “Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: current status and major issues,” Neurobiology of Aging, vol. 18, no. 4 suppl, pp. S43–S50, 1997. View at Publisher · View at Google Scholar
  3. J C Morris, “Mild cognitive impairment and preclinical Alzheimer's disease,” Geriatrics, vol. 60, no. 6 suppl, pp. 9–14, 2005.
  4. R C Petersen, R Doody, A Kurz, et al., “Current concepts in mild cognitive impairment,” Archives of Neurology, vol. 58, no. 12, pp. 1985–1992, 2001. View at Publisher · View at Google Scholar
  5. J N Keller, F A Schmitt, S W Scheff, et al., “Evidence of increased oxidative damage in subjects with mild cognitive impairment,” Neurology, vol. 64, no. 7, pp. 1152–1156, 2005.
  6. L M Sayre, M A Smith, and G Perry, “Chemistry and biochemistry of oxidative stress in neurodegenerative disease,” Current Medicinal Chemistry, vol. 8, no. 7, pp. 721–738, 2001.
  7. M J Picklo, T J Montine, V Amarnath, et al., “Carbonyl toxicology and Alzheimer's disease,” Toxicology and Applied Pharmacology, vol. 184, no. 3, pp. 187–197, 2002. View at Publisher · View at Google Scholar
  8. Q Ding, W R Markesbery, Q Chen, et al., “Ribosome dysfunction is an early event in Alzheimer's disease,” Journal of Neuroscience, vol. 25, no. 40, pp. 9171–9175, 2005. View at Publisher · View at Google Scholar
  9. W R Markesbery, R J Kryscio, M A Lovell, et al., “Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment,” Annals of Neurology, vol. 58, no. 5, pp. 730–735, 2005. View at Publisher · View at Google Scholar
  10. J Wang, S Xiong, C Xie, et al., “Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease,” Journal of Neurochemistry, vol. 93, no. 4, pp. 953–962, 2005. View at Publisher · View at Google Scholar
  11. B I Giasson, H Ischiropoulos, V M Lee, and J Q Trojanowski, “The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases,” Free Radical Biology and Medicine, vol. 32, no. 12, pp. 1264–1275, 2002. View at Publisher · View at Google Scholar
  12. P Jenner and C W Olanow, “Understanding cell death in Parkinson's disease,” Annals of Neurology, vol. 44, no. 3 suppl 1, pp. S72–S84, 1998.
  13. R S Sohal, “ Role of oxidative stress and protein oxidation in the aging process,” Free Radical Biology and Medicine, vol. 33, no. 1, pp. 37–44, 2002. View at Publisher · View at Google Scholar
  14. B A Bahr and J Bendiske, “The neuropathogenic contributions of lysosomal dysfunction,” Journal of Neurochemistry, vol. 83, no. 3, pp. 481–489, 2002. View at Publisher · View at Google Scholar
  15. T Grune, K Merker, G Sandig, et al., “Selective degradation of oxidatively modified protein substrates by the proteasome,” Biochemical and Biophysical Research Communications, vol. 305, no. 3, pp. 709–718, 2003. View at Publisher · View at Google Scholar
  16. N S Langstrom, J P Anderson, H G Lindroos, et al., “Alzheimer's disease-associated reduction of polysomal mRNA translation,” Molecular Brain Research, vol. 5, no. 4, pp. 259–269, 1989. View at Publisher · View at Google Scholar
  17. K Honda, M A Smith, X Zhu, et al., “Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron,” Journal of Biological Chemistry, vol. 280, no. 22, pp. 20978–20986, 2005. View at Publisher · View at Google Scholar
  18. B Langley, J M Gensert, M F Beal, et al., “Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents,” Current Drug Targets, vol. 4, no. 1, pp. 41–50, 2005. View at Publisher · View at Google Scholar
  19. G A Soliman, “The mammalian target of rapamycin signalling network and gene regulation,” Current Opinion in Lipidology, vol. 16, no. 3, pp. 317–323, 2005. View at Publisher · View at Google Scholar
  20. H Ryu, K Smith, S I Camelo, et al., “Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice,” Journal of Neurochemistry, vol. 93, no. 5, pp. 1087–1098, 2005. View at Publisher · View at Google Scholar